Tricuspid valve replacement in rheumatic heart disease.
The diagnosis of tricuspid valve disease is often difficult; the best treatment is not yet established. Twenty patients had tricuspid valve replacements at St. Thomas's Hospital as part of multiple valve replacement procedures. The hospital mortality was 25%, most deaths being due to a low cardiac output causing hepatorenal failure. Preoperative cardiac cachexia had a fatal outcome in all cases. Except in two instances, surviving patients returned to a satisfactory level of activity.
D000293:Adolescent; D000328:Adult; D002302:Cardiac Output; D006348:Cardiac Surgical Procedures / Q000401:mortality; D005260:Female; D006350:Heart Valve Prosthesis; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D007565:Jaundice / Q000150:complications; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology / Q000517:prevention & control; D012214:Rheumatic Heart Disease / Q000150:complications*; D014262:Tricuspid Valve Insufficiency / Q000601:surgery*
D007545:Isoproterenol